BusinessMelinta Therapeutics to Present at The Cowen and Company 38th Annual Health Care ConferenceBy Nasdaq OMXMar 2, 2018, 12:00 PM UTC
BusinessMelinta Therapeutics Publishes Complete Results from Phase 3 TANGO I Study of VABOMERE™ (meropenem and vaborbactam) in Patients with cUTIBy Nasdaq OMXFeb 27, 2018, 9:05 PM UTC
